We are live on
!
Find out more
DVC
Deer VII & Co Portfolio holdings
AUM
$317M
1-Year Est. Return
30.89%
This Fund
S&P 500
This Quarter
Est. Return
+34.06%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
–
AUM
$67.5M
AUM Growth
–
Cap. Flow
+$58.7M
Cap. Flow
% of AUM
86.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tempest Therapeutics
TPST
|
+$30.7M |
| 2 |
Verastem
VSTM
|
+$20M |
| 3 |
Insmed
INSM
|
+$7.89M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
DCM
TPCM
UTC
KCP
DMK
FA
HCIA
OH
Deer VII & Co's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Deer VII & Co, which disclosed 3 positions worth $67.5M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Tempest Therapeutics: 818 shares worth $30.8M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Deer VII & Co's largest Q2 2013 buy was Tempest Therapeutics: 818 shares worth $30.8M.
- Deer VII & Co's ten largest holdings make up 100% of its $67.5M portfolio in Q2 2013.
- Deer VII & Co disclosed 3 positions in Q2 2013, its first 13F filing on record.
Based on Deer VII & Co's 13F filing for Q2 2013, filed 14 Aug 2013.